Skip to content

Net margin at other companies

Alkermes logo
AlkermesALKS
9.8%-13.5pp
JAN
Janus Living JAN
-2,552.7%-2,601pp

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%
Enterprise value$4.86B+242%
P/E18×
P/S3.5×+2.3×

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
FCF margin-14.9%

Returns & leverage

See full
Return on equity-117%
Debt / equity-3.5×
Current ratio0.9×0.0×

Where this comes from

Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's net margin?
Indivior Pharmaceuticals, Inc. (INDV) reported net margin of 19.4% in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's net margin changed year-over-year?
Indivior Pharmaceuticals, Inc. 's net margin increased by 3352.3% year-over-year, from -0.6% to 19.4%.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's net margin?
Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's net margin has grown at a 53.5% compound annual growth rate (CAGR), from -4.7% to 16.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.